GlaxoSmithKline PLC Director/PDMR Shareholding (8795R)

TIDMGSK

RNS Number : 8795R

GlaxoSmithKline PLC

01 July 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc ('Company').

On 30 June 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of GBP13.45 per Ordinary Share, and notional ADSs at a price of $42.20 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2015 to 30 June 2015:

 
 Non Executive         Ordinary 
  Director              Shares     No. of ADSs 
 Sir Philip Hampton    2,730.912 
 Professor Sir 
  Roy Anderson           673.792 
 Dr Stephanie Burns                    539.199 
 Stacey Cartwright       534.387 
 Lynn Elsenhans                      1,070.720 
 Judy Lewent                           457.147 
 Sir Deryck Maughan                  1,359.719 
 Dr Daniel Podolsky                  1,019.789 
 Urs Rohner              589.536 
 Hans Wijers             534.387 
 
 

The Company and the Non-Executive Directors were informed of these allocations on 1 July 2015.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 July 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLFLFBEDFEBBL